Custom antibody development

We offer world-leading antibody development platforms based on a proprietary RabMAb® rabbit monoclonal platform, a phase display platform (AxioMx), and a next-generation sequencing platform (NGS-RabMAb®)

Applications

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application

Abreviews

Notes

ELISA

Sandwich ELISA

WB

Application notes

ELISA: Use at a concentration of 0.25 - 1 µg/ml. Allows the detection of at least 0.2 - 0.4 ng/well of recombinant Human IL28A.
sELISA: Use at a concentration of 0.25 - 1 µg/ml. Allows the detection of at least 0.2 - 0.4 ng/well of recombinant Human IL28A.
WB: Use at a concentration of 0.1 - 0.2 µg/ml. The detection limit for recombinant Human IL28A is 1.5 - 3.0 ng/lane under either reducing or non-reducing conditions. Predicted molecular weight: 22 kDa.

Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.